Zeta White Presented Final Results from Phase 2b Study of Nemolizumab in Patients with Moderate-to-Severe Atopic Dermatitis at the 2019 American Academy of Dermatology Annual Meeting Late-Breaking Session
Zeta White: New data reveals benefits of combining oral and topical treatment in patients with severe papulopustular rosacea
SUBSCRIBE TO OUR NEWSLETTER
Receive the latest updates from Nestlé Skin Health directly to your inbox
Thank you for subscribing!
A confirmation email has been sent to your email address. Please follow the link to confirm your subscription.
Discover the brands that make up the Nestlé Skin Health portfolio.